Skip to main content

Find Clinical Trials

Home
Conditions
ALK-positive Non-small Cell Lung Cancer (NSCLC)

Clinical trial condition

ALK-positive Non-small Cell Lung Cancer (NSCLC)

Explore clinical trials studying ALK-positive Non-small Cell Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

ALK-positive Non-small Cell Lung Cancer (NSCLC) trial results

Recruiting

Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib

NCT07633626

Conditions: ALK-positive Non-small Cell Lung Cancer (NSCLC), Adenocarcinoma, Adenocarcinoma of Lung, +23 more
Locations: Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo CTIC Bogotá, Colombia

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study

NCT06785584

Conditions: ALK-positive Advanced NSCLC, ALK-positive Non-small Cell Lung Cancer (NSCLC), MPR, +1 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

View Trial Details

Active, Not Recruiting

Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms

NCT05987956

Conditions: ALK-positive Non-small Cell Lung Cancer (NSCLC)
Locations: Omnicure Clinical Research Doral, Florida, United States

Medicine Invention Design, Inc. - IORG0007849 - NPI 1023387701 Rockville, Maryland, United States

View Trial Details